Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Schizophrenia
Related studies linked through entity extraction aliases.
Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Psychiatric Disorders and Electrophysiological Markers
- Status
- UNKNOWN
- Phase
- NA
Exercise and Cognitive Training
- Status
- COMPLETED
- Phase
- NA
The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder
- Status
- UNKNOWN
- Phase
- N/A
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE1
Task Sharing for the Care of Severe Mental Disorders in a Low-income Country
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
- Status
- COMPLETED
- Phase
- PHASE4
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Dyad Oxytocin Study (DOS)
- Status
- COMPLETED
- Phase
- PHASE1
Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
Confirmatory Study of DSP-5423P in Patients With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Effect of Dosing on Clozapine Levels
- Status
- WITHDRAWN
- Phase
- PHASE4
A Trial to Assess the Antipsychotic Efficacy of ITI-007
- Status
- COMPLETED
- Phase
- PHASE3
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
- Status
- UNKNOWN
- Phase
- PHASE4
A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.
- Status
- COMPLETED
- Phase
- PHASE2
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain
- Status
- COMPLETED
- Phase
- N/A
Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3